Middle East and Africa Tumor Ablation Market Report and Forecast 2024-2032

Middle East and Africa Tumor Ablation Market Analysis

Tumor ablation is a technique that can destroy tumor cells with minimal damage to the surrounding tissues. The procedure involves inserting a needle or probe directly into the tumor, guided by the help of imaging techniques like ultrasound, CT, or MRI. It is increasingly utilized in treating small and localized tumors and is a promising alternative for patients who are not eligible for traditional surgery. The rising adoption of this treatment modality due to its minimally invasive nature and high precision approach is significantly contributing to the Middle East and Africa tumor ablation market growth.

In the Middle East and Africa, cancer is becoming one of the leading causes of disease burden, with patient numbers projected to sharply rise in the coming decades . Recent data reveals that the number of new cancer cases in Saudi Arabia is estimated to reach 60,429 by 2040, indicating the need for effective interventions to treat the growing patient pool. Since tumor ablation can be used in the treatment of various types of cancers, including liver, kidney, lung, and bone cancers, the high cancer incidence is expected to directly impact the Middle East and Africa tumor ablation market demand.

One of the major market trends is the increasing introduction of advanced ablation techniques in healthcare facilities in the region due to their higher efficacy and fewer side effects. In January 2023, Tawam Hospital, part of the Abu Dhabi Health Services Company (the United Arab Emirates’ largest healthcare network) announced that they used a thyroid radiofrequency and microwave ablation procedure for the first time to treat a patient with a large compressive benign thyroid nodule. Further, they shared that the patient was successfully treated with this novel procedure and was discharged after an hour. The growing recognition of tumor ablation technique as a reasonable alternative to surgery is likely to improve patient outcomes and quality of life, thereby elevating the Middle East and Africa tumor ablation market value.

The market is also influenced by the increased government initiatives aimed at improving cancer care and treatment access. For instance, in August 2023, the Federal Ministry of Health, Federal Capital Territory Administration, the Clinton Health Access Initiative, Medicaid Cancer Foundation, and City Cancer Challenge Foundation (C/Can) signed a Memorandum of Understanding to tackle the cancer burden in Abuja (Nigeria) and improve cancer care across the region. The multi-stakeholder commitment is to facilitate the reduction of cancer incidence and mortality through sustainable cancer care solutions. Such collaborative efforts are poised to increase access to innovative cancer treatment options including tumor ablation therapy in the region, which is anticipated to boost the market share.

Middle East and Africa Tumor Ablation Market Report Snapshots

Middle East and Africa Tumor Ablation Market Size

Middle East and Africa Tumor Ablation Market Analysis

Middle East and Africa Tumor Ablation Companies